Publication | Closed Access
TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway
42
Citations
20
References
2022
Year
The combination of sorafenib and GPX4 inhibitors such as RSL3 may be a promising therapy against CRC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1